- Home
- AGEN vs AMLI Comparison
AGEN vs AMLI Comparison
Compare AGEN & AMLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- AMLI
- Stock Information
- Founded
- AGEN 1994
- AMLI 1974
- Country
- AGEN United States
- AMLI Canada
- Employees
- AGEN N/A
- AMLI N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- AMLI Industrial Machinery/Components
- Sector
- AGEN Health Care
- AMLI Industrials
- Exchange
- AGEN Nasdaq
- AMLI Nasdaq
- Market Cap
- AGEN 96.2M
- AMLI 85.8M
- IPO Year
- AGEN 2000
- AMLI N/A
- Fundamental
- Price
- AGEN $2.83
- AMLI $0.36
- Analyst Decision
- AGEN Buy
- AMLI Strong Buy
- Analyst Count
- AGEN 3
- AMLI 1
- Target Price
- AGEN $10.50
- AMLI $3.25
- AVG Volume (30 Days)
- AGEN 566.5K
- AMLI 960.2K
- Earning Date
- AGEN 11-12-2024
- AMLI 01-14-2025
- Dividend Yield
- AGEN N/A
- AMLI N/A
- EPS Growth
- AGEN N/A
- AMLI N/A
- EPS
- AGEN N/A
- AMLI N/A
- Revenue
- AGEN $160,427,000.00
- AMLI N/A
- Revenue This Year
- AGEN N/A
- AMLI N/A
- Revenue Next Year
- AGEN $36.13
- AMLI N/A
- P/E Ratio
- AGEN N/A
- AMLI N/A
- Revenue Growth
- AGEN 59.00
- AMLI N/A
- 52 Week Low
- AGEN $2.50
- AMLI $0.32
- 52 Week High
- AGEN $19.69
- AMLI $1.24
- Technical
- Relative Strength Index (RSI)
- AGEN 39.40
- AMLI 24.97
- Support Level
- AGEN $2.65
- AMLI $0.34
- Resistance Level
- AGEN $3.85
- AMLI $0.70
- Average True Range (ATR)
- AGEN 0.29
- AMLI 0.04
- MACD
- AGEN -0.02
- AMLI -0.02
- Stochastic Oscillator
- AGEN 15.00
- AMLI 5.76
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About AMLI American Lithium Corp.
American Lithium Corp is an exploration-stage company. It is engaged in the identification, acquisition, and exploration of mineral interests in the United States of America and Peru. Its projects include TLC Lithium, Falchani Lithium, and Macusani Uranium project.